您当前所在的位置:首页 > 产品中心 > 产品信息
RETRA_分子结构_CAS_)
点击图片或这里关闭

RETRA

产品号 R1906 公司名称 Sigma Aldrich
CAS号 公司网站 http://www.sigmaaldrich.com
分子式 C11H12ClNO3S2 电 话 1-800-521-8956
分子量 305.80088 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154425

产品价格信息

请登录

产品别名

标题
RETRA
IUPAC标准名
2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-(3,4-dihydroxyphenyl)ethan-1-one hydrochloride
IUPAC传统名
2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-(3,4-dihydroxyphenyl)ethanone hydrochloride
别名
2-(4,5-Dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone hydrochloride
Reactivation of Transcriptional Reporter Activity

产品登记号

MDL号 MFCD11114394

产品性质

Empirical Formula (Hill Notation) C11H12ClNO3S2
纯度 ≥98% (HPLC)
外观 white solid
溶解度 DMSO: >20 mg/mL
GHS危险品标识 GHS06
GHS警示词 Danger
GHS危险声明 H301
欧盟危险性物质标志 有毒(Toxic) 有毒(Toxic) (T)
MSDS下载 下载链接
个人保护装置 Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS警示性声明 P301 + P310
RID/ADR UN 2811 6.1/PG 1
危险公开号 25
安全公开号 45
保存温度 2-8°C
联合国危险货物等级 6.1
联合国危险货物编号 2811
联合国危险货物包装类别(PG) 1
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
RETRA is a mutant p53-dependent activator of p73, an activator of p53-regulated genes, and a suppressor of mutant p53-bearing tumor cells. Greater than 50% of tumors express mutant p53 which is defective for the tumor-suppressor function and contributes to malignancy by blocking a p53 family member p73. Activation of p73 in human cancer produces a cytotoxic effect. RETRA increases expression level of p73 and releases p73 from the inhibitory complex with mutant 53. It thereby produces tumor-supressor effect, in vitro and in vivo, similar to functional reactivation of p53.
详细说明 (简体中文)
Biochem/physiol Actions
RETRA is a mutant p53-dependent activator of p73, an activator of p53-regulated genes, and a suppressor of mutant p53-bearing tumor cells. Greater than 50% of tumors express mutant p53 which is defective for the tumor-suppressor function and contributes to malignancy by blocking a p53 family member p73. Activation of p73 in human cancer produces a cytotoxic effect. RETRA increases expression level of p73 and releases p73 from the inhibitory complex with mutant 53. It thereby produces tumor-supressor effect, in vitro and in vivo, similar to functional reactivation of p53.

参考文献